Last updated: February 10, 2026
Case Overview
Sun Pharmaceutical Industries, Inc. filed a patent infringement lawsuit against Perrigo Company in the District of Delaware. The case number is 1:18-cv-00703, filed in March 2018. Sun alleges Perrigo infringed its patent on a formulation related to a generic drug product.
Patent at Issue
- Patent Number: US Patent No. 9,982,044
- Title: "Stable Liquid Formulations"
- Issued: May 29, 2018
- Claims focus on a liquid pharmaceutical composition, emphasizing stability and bioavailability improvements.
Core Allegations
Sun claims Perrigo's generic version of a drug violates the '044 patent by manufacturing and marketing a similar liquid formulation without authorization. Sun seeks injunctive relief, damages, and an accounting of profits.
Legal Grounds
- Patent infringement under 35 U.S.C. § 271(a)
- Patent validity challenged by Perrigo in subsequent proceedings
- Defenses included non-infringement and patent invalidity
Key Procedural Points
- Complaint filed: March 5, 2018
- Markman hearing (claim interpretation): October 2018
- Summary judgment motions filed in mid-2019
- Trial scheduled for December 2020 but postponed due to settlement discussions
Outcome & Current Status
- Settled in July 2020 before trial
- Terms undisclosed
- Court dismissed the case with prejudice following settlement
Litigation Highlights
-
Claim Construction
The court's Markman order clarified the scope of pivotal claims, emphasizing the "stability" element as a primary distinguishing feature over prior art.
-
Invalidity Challenges
Perrigo's defense flagged alleged prior art references published before the patent's priority date, arguing the claims were anticipated and obvious.
-
Settlement Impact
The resolution prevented a formal ruling on patent validity and infringement, marking a typical resolution to patent litigation involving high-value drugs.
-
Impact on Industry
The case highlights challenges faced by generic companies in navigating patent landscapes for liquid formulations, especially amid aggressive patenting strategies.
Legal Implications
- The case underscores the importance of precise claim language, especially around stability features.
- Patent validity remains a contentious issue in pharmaceutical patent litigation.
- Settlements often obviate the need for lengthy, costly trials but leave residual questions about patent strength.
Analysis
Perrigo's defenses suggest that generic companies heavily rely on invalidity arguments to counter patent infringement claims. The case exemplifies strategic use of claim construction proceedings to narrow patent scope early in litigation. While the settlement closes this chapter, the underlying patent remains enforceable until challenged anew or invalidated through separate proceedings.
Market implications include potential delays in generic entry, which could extend exclusivity periods for Sun's product. The dispute reflects broader tensions between innovator firms and generics, especially relating to formulations with purported stability advantages.
Key Takeaways
- The determination of patent scope via claim construction can significantly influence litigation outcomes.
- Settlements can prevent en banc rulings on patent validity, continuing uncertainties in patent strength.
- Patent challenges utilizing prior art require careful timing and documentation.
- Liquid formulation patents in pharma are highly scrutinized; claims must be well-delineated to withstand challenges.
- Litigation can extend market exclusivity or delay generic competition, affecting drug pricing and access.
FAQs
-
What was the main legal issue in Sun v. Perrigo?
Whether Perrigo's generic liquid formulation infringed Sun’s '044 patent covering stable liquid pharmaceutical compositions.
-
Did the court decide on patent infringement?
No. The case settled before a final judgment on infringement was made.
-
Were there notable validity challenges to the patent?
Perrigo argued prior art anticipated or rendered the patent obvious, but these issues remained unresolved due to settlement.
-
What impact does settlement have on patent enforcement?
Settlements prevent a court ruling on patent validity and infringement, leaving patent enforceability intact but unresolved in this case.
-
How does claim construction influence patent litigation?
It defines the scope of patent claims, shaping defenses and infringement analysis.
References
[1] Docket entries and filings for Sun Pharmaceutical Industries, Inc. v. Perrigo Company, District of Delaware, Case No. 1:18-cv-00703.
